1-3 of 3
Liam Smyth, MDFRCPath
Close
Sort by
Journal Articles

Predictors of Healthcare Utilization in Newly Diagnosed Myeloma

Shane Toolan, MRCP, Mark Griffin, MB BCh BAO, Mark Coyne, Kate O'Mahony, BSc Pharm, Joy Lewis, Chandan D'Souza, Daniel G Connaghan, MD, Karen Murphy, MD, Kamal Fadalla, FRCPath, Joan Marie Fitzgerald, BSc, FRCPath, MBBChir, Conor Collins, Niall Swan, MRCP, MB, Crotty Tom, Gibbons David, Liam Smyth, MDFRCPath
Journal: Blood
Blood (2020) 136 (Supplement 1): 37–38.
https://doi.org/10.1182/blood-2020-138857
Published: 2020
Journal Articles

Statin and COX-2 Inhibitor Exposure Is Associated with Improved Survival in 4913 Newly Diagnosed DLBCL Patients: A Large Population Based Study

Liam Smyth, MDFRCPath, Danielle N. Blunt, BMBS, Evgenia Gatov, Chenthila Nagamuthu, MPH, Ruth Croxford, MSc, Lee Mozessohn, MD, Matthew Cheung, MDMSc
Journal: Blood
Blood (2019) 134 (Supplement_1): 3476.
https://doi.org/10.1182/blood-2019-127156
Published: 2019
Journal Articles

Combination of DPX-Survivac, Low Dose Cyclophosphamide, and Pembrolizumab in Recurrent/Refractory DLBCL: The Spirel Study

Neil L Berinstein, MD, Isabelle Bence-Bruckler, MD, Pierre Laneuville, MD FRCPC, Douglas A. Stewart, MD, Nicholas Allen Forward, MDMSc,FRCPC, Liam Smyth, MDFRCPath, Gail Klein, MSc, Nancy Pennell, BSc, Kim Roos, BA, BSc
Journal: Blood
Blood (2019) 134 (Supplement_1): 3236.
https://doi.org/10.1182/blood-2019-125963
Published: 2019